Clincosm LogoSign in Get a demo

Head and Neck Cancer

Showing NaN - NaN of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Experimental Observation
  • +3 more
  • Baltimore, Maryland
  • +5 more
Oct 16, 2023

Upper Aerodigestive Malignancies

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Collection of biological specimens
  • Baltimore, Maryland
    Johns Hopkins University
Aug 9, 2023

Brain Tumor, Head Neck Cancer Trial in Washington, Baltimore (radiation, other, diagnostic test)

Not yet recruiting
  • Brain Tumor
  • Head and Neck Cancer
  • substructure informed planning
  • +2 more
  • Washington, District of Columbia
  • +1 more
Dec 13, 2022

Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

Recruiting
  • Head and Neck Cancer
  • Scottsdale, Arizona
  • +87 more
Dec 12, 2022

Head Neck Cancer Trial in Baltimore, Chapel Hill, Philadelphia (Pembrolizumab, Intensity Modulated Radiation Therapy)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Baltimore, Maryland
  • +2 more
Dec 7, 2022

Head Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma Trial in United States (CUE-101,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Tucson, Arizona
  • +16 more
Nov 15, 2022

Head Neck Cancer, Human Papilloma Virus Trial in United States (MEDI0457, CELLECTRA®5P device, Durvalumab)

Completed
Has Results
  • Head and Neck Cancer
  • Human Papilloma Virus
  • San Francisco, California
  • +13 more
Aug 3, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Enoblituzumab, Retifanlimab,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Enoblituzumab
  • +2 more
  • Baltimore, Maryland
  • +41 more
May 16, 2022

Head Neck Cancer, Oropharynx Cancer, Oropharyngeal Squamous Cell Carcinoma Trial in United States (Intensity modulated

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)
  • Baltimore, Maryland
  • +5 more
Apr 26, 2022

Head Neck Cancer Trial in Canada, Saudi Arabia, United States (cisplatin, 3-dimensional conformal radiation therapy,

Active, not recruiting
  • Head and Neck Cancer
  • Birmingham, Alabama
  • +267 more
Apr 6, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Nivolumab 480mg and surgical resection
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Feb 25, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab, Cisplatin/Carboplatin;

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

Completed
  • Melanoma
  • +3 more
  • Enoblituzumab
  • +2 more
  • Scottsdale, Arizona
  • +19 more
Sep 22, 2021

Head Neck Cancer Trial in Worldwide (cetuximab, intensity-modulated radiation therapy)

Active, not recruiting
  • Head and Neck Cancer
  • cetuximab
  • intensity-modulated radiation therapy
  • Birmingham, Alabama
  • +263 more
Aug 2, 2021

Head Neck Cancer Trial in United States (docetaxel, irinotecan HCl)

Completed
  • Head and Neck Cancer
  • Birmingham, Alabama
  • +42 more
Nov 5, 2020

Anemia, Head Neck Cancer Trial in Canada, Korea, Republic of, United States (biological, drug, radiation)

Completed
  • Anemia
  • Head and Neck Cancer
  • epoetin alfa
  • +2 more
  • Birmingham, Alabama
  • +260 more
Oct 21, 2020

Head Neck Cancer Trial in Canada, United States (cisplatin, radiation therapy)

Completed
  • Head and Neck Cancer
  • Birmingham, Alabama
  • +257 more
Oct 21, 2020

Head Neck Cancer, Skin Reactions Secondary to Radiation Therapy Trial in Canada, United States (drug, procedure, radiation)

Completed
  • Head and Neck Cancer
  • Skin Reactions Secondary to Radiation Therapy
  • Biafine cream
  • +2 more
  • Birmingham, Alabama
  • +259 more
Oct 21, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020